Work

Randomized phase IIb trial of a CMV vaccine immunotherapeutic candidate (VBI-1901) in recurrent glioblastomas.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.tps2100

Authors: Ryan Thomas Merrell, Patrick Y. Wen, Deborah Anne Forst, Jessica Schulte, Yazmin Odia, Daniela Annenelie Bota, Francisco Diaz-Mitoma, David E Anderson, Andrew B. Lassman, Fabio Massaiti Iwamoto

Institutions: Vanderbilt University, Harvard University, Dana-Farber Cancer Institute, Massachusetts General Hospital, University of California San Diego, University of California, Irvine Medical Center, Columbia University, Columbia University Irving Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4400522274

Cites:

Cited by: 4

Related to: 10